John and Jordan discuss the unethical behavior of medical journals in the Vioxx scandal, where they continued to sell reprints of an inaccurate article to Merck despite knowing the risks associated with the drug. The sale of reprints was a significant source of income for these journals, highlighting the financial incentives that can compromise scientific integrity.
